Spotlight: Acucela's Ryo Kubota, Entrepreneur of 2012 Finalist Ryo Kubora performed nearly a thousand eye surgeries and discovered the gene that causes glaucoma, before starting his biotech company, Acucela. His innovation in the field of eye diseases makes him a finalist for Entrepreneur of 2012.

By Jane Porter

entrepreneur daily

Opinions expressed by Entrepreneur contributors are their own.

Spotlight Acucelas Ryo Kubota Entrepreneur of 2012 Finalist

Editor's Note: Each year, we honor a top entrepreneur in our annual Entrepreneur contest. Meet the finalists in the running for Entrepreneur of 2012. Here, a look at Ryo Kubota, founder of Acucela.

Even before Ryo Kubota founded Acucela, a biotechnology company focused on developing therapies for blinding eye diseases, he had an accomplish resume. Early in his career while performing ocular surgery in Keio University in Japan, Kubota discovered the gene that causes glaucoma and performed close to a thousand eye surgeries. Growing increasingly frustrated by the lack of adequate treatment available for devastating eye diseases, Kubota came to the U.S. to expand his research. In 2002, he founded Acucela out of the basement of his home.

In the years since, Acucela has developed oral drugs that have the ability to slow blinding eye diseases like dry age-related macular degeneration, retinopathy of prematurity, Stargardt disease and diabetic retinopathy, which affect millions of people around the world. Today, Acucela is in the second phase of clinical trials for a once-a-day pill that uses a specific enzyme to reduce toxic byproducts that accumulate in the back of the eye, causing glaucoma. "I strongly believe the treatment paradigm in ophthalmology has to be changed," he says. "Instead of injecting things into the eye, we want to do something non-invasively."

Related: 5 Ways Technology Can Help Improve Your Health

By developing less invasive treatments for blinding eye diseases, Kubota hopes to be able to offer oral medication that can cure blinding eye diseases and treat them in their early stages. "The mission that we have is global," says Kubota. "There is no border for disease or drug."
The Seattle-based company now has 80 employees, and in 2011, Acucela made $34.2-million in sales. But despite the strides made in ocular research, Kubota is confident there is still much to be done in terms of discovery in the field. "The ophthalmology space is still relatively untapped in terms of drug development," he says. "Now ophthalmology is the front runner for innovation."

Related: Meet the Finalists for 'Entrepreneur of 2012' and Watch Their Inspirational Stories

Should Ryo Kubota be Entrepreneur of 2012? Vote for him here.

Related: Sentek Global's Eric Basu, Entrepreneur of 2012 Finalist

Related: Adafruit Industries' Limor Fried, Entrepreneur of 2012 Finalist

Related: Fair Trade USA's Paul Rice, Entrepreneur of 2012 Finalist

Related: Justin's Nut Butter's Justin Gold, Entrepreneur of 2012 Finalist

Jane Porter

Writer and editor

Jane Porter is a freelance writer and editor based in Brooklyn, NY. You can find more of her work at Janeroseporter.com

Want to be an Entrepreneur Leadership Network contributor? Apply now to join.

Editor's Pick

Related Topics

Starting a Business

This Retiree's Leisurely Side Hustle Makes $66,000 a Year and, 'You Don't Even Need to Go to High School to Do It'

Barbara Hill wanted a flexible, part-time job that would transition well into retirement. Now she mentors younger people who are making over $200,000 a year. Here's her insider's guide to getting started.

Marketing

The Miley Cyrus Approach To Marketing — Why It's a Radically Different Method For Achieving Brand Impact

In case you missed it, Miley Cyrus recently won her first Grammy. In her acceptance speech, she told a story that is a great learning lesson for business owners and marketers alike, especially those who find themselves burned out and exhausted in this current environment.

Business News

HP Wants You to 'Never Own A Printer Again,' Launches Rental Subscription

In February, HP's CEO Enrique Lores stated that making printing a subscription service was the company's "long-term objective."

Business News

IKEA Price Increases Are Going Viral — Here's How Much Your Favorite Couch Costs Now: 'Inflation Is Crazy'

A video with a customer complaining about "inflation" and "corporate greed" has racked up over 1.3 million views on TikTok.